|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 3310814 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16733812.8 |
| Date of filing the European patent application | 2016-06-16 | |
| (97) | Date of publication of the European application | 2018-04-25 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-02 |
| (46) | Date of publication of the claims translation | 2023-10-10 |
| (86) | Number | PCT/US2016/037879 |
| Date | 2016-06-16 |
| (87) | Number | WO 2016/205520 |
| Date | 2016-12-22 |
| (30) | Number | Date | Country code |
| 201562180459 P | 2015-06-16 | US |
| (72) |
HOTZEL, Isidro , US
JUNTTILA, Teemu, T. , US
LI, Ji , US
SCHEER, Justin , US
DICARA, Danielle , US
ELLERMAN, Diego , US
SPIESS, Christoph , US
CARTER, Paul , US
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Humanizuoti ir subrendusio giminingumo antikūnai prieš FcRH5 ir jų naudojimo būdai |
| HUMANIZED AND AFFINITY MATURED ANTIBODIES TO FCRH5 AND METHODS OF USE |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 10 | 231.00 EUR |
| 2026-06-16 |